dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution
dorzolamide
RxCUI: 1923432
What the CMS Formulary Data Shows for dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution
Per the CMS 2026 Part D formulary file, dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution (RxNorm concept RXCUI 1923432, generic name dorzolamide) appears on 330 distinct formulary files spanning 5,067 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 3, with a cross-plan average of Tier 1.6.
Real-world access to dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0.6% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 710,453 Part D beneficiaries filled dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution in 2023, with total plan-and-beneficiary spending of $81,680,075 and an average per-beneficiary annual cost of $114.97. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution today.
Coverage Details
- Formularies covering
- 330
- Plans covering
- 5,067
- Coverage rate
- 100%
- Tier range
- Tier 1 – Tier 3
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0.6% of formularies
2023 Medicare Spending
- Beneficiaries
- 710,453
- Total spending
- $81,680,075
- Avg per beneficiary
- $114.97
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution covered by Medicare Part D?
Yes, dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution is covered by 5,067 Medicare Part D plans (100% of all Part D formularies).
What tier is dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution on Medicare Part D plans?
dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution averages Tier 1.6 across Part D plans, ranging from Tier 1 to Tier 3.
Does dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution require prior authorization?
0% of Part D formularies require prior authorization for dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution. Step therapy: 0%. Quantity limits: 0.6%.
How much does Medicare spend on dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution?
In 2023, total Medicare Part D spending on dorzolamide 20 MG/ML / timolol 5 MG/ML Ophthalmic Solution was $81,680,075, covering 710,453 beneficiaries. The average spend per beneficiary was $114.97.
Read our methodology - how this data is sourced, computed, and verified.